These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30540704)

  • 1. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
    Davidovics ZH; Michail S; Nicholson MR; Kociolek LK; Pai N; Hansen R; Schwerd T; Maspons A; Shamir R; Szajewska H; Thapar N; de Meij T; Mosca A; Vandenplas Y; Kahn SA; Kellermayer R;
    J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):130-143. PubMed ID: 30540704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addendum for: Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
    J Pediatr Gastroenterol Nutr; 2020 Mar; 70(3):404. PubMed ID: 31880660
    [No Abstract]   [Full Text] [Related]  

  • 3. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).
    Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection.
    Song Y; Garg S; Girotra M; Maddox C; von Rosenvinge EC; Dutta A; Dutta S; Fricke WF
    PLoS One; 2013; 8(11):e81330. PubMed ID: 24303043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
    Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
    Girotra M; Garg S; Anand R; Song Y; Dutta SK
    Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
    Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT
    J Hosp Infect; 2024 Jun; 148():189-219. PubMed ID: 38609760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of faecal microbiota transplant as treatment for recurrent or refractory
    Mullish BH; Merrick B; Quraishi MN; Bak A; Green CA; Moore DJ; Porter RJ; Elumogo NT; Segal JP; Sharma N; Marsh B; Kontkowski G; Manzoor SE; Hart AL; Settle C; Keller JJ; Hawkey P; Iqbal TH; Goldenberg SD; Williams HRT
    Gut; 2024 Jun; 73(7):1052-1075. PubMed ID: 38609165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection.
    Varier RU; Biltaji E; Smith KJ; Roberts MS; Kyle Jensen M; LaFleur J; Nelson RE
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):438-44. PubMed ID: 25782899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fecal microbiota transplantation].
    García-García-de-Paredes A; Rodríguez-de-Santiago E; Aguilera-Castro L; Ferre-Aracil C; López-Sanromán A
    Gastroenterol Hepatol; 2015 Mar; 38(3):123-34. PubMed ID: 25454597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center.
    Ianiro G; Bibbò S; Porcari S; Settanni CR; Giambò F; Curta AR; Quaranta G; Scaldaferri F; Masucci L; Sanguinetti M; Gasbarrini A; Cammarota G
    Gut Microbes; 2021; 13(1):1994834. PubMed ID: 34709989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal microbiota transplantation in patients with
    Lahtinen P; Mattila E; Anttila VJ; Tillonen J; Teittinen M; Nevalainen P; Salminen S; Satokari R; Arkkila P
    World J Gastroenterol; 2017 Oct; 23(39):7174-7184. PubMed ID: 29093626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.
    Sokol H; Galperine T; Kapel N; Bourlioux P; Seksik P; Barbut F; Scanzi J; Chast F; Batista R; Joly F; Joly AC; Collignon A; Guery B; Beaugerie L;
    Dig Liver Dis; 2016 Mar; 48(3):242-7. PubMed ID: 26433619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota restoration therapies for recurrent
    DuPont HL; DuPont AW; Tillotson GS
    Therap Adv Gastroenterol; 2024; 17():17562848241253089. PubMed ID: 38800353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal Microbiota Transplantation and Medical Therapy for Clostridium difficile Infection : Meta-analysis of Randomized Controlled Trials.
    Singh T; Bedi P; Bumrah K; Gandhi D; Arora T; Verma N; Schleicher M; Rai MP; Garg R; Verma B; Sanaka MR
    J Clin Gastroenterol; 2022 Nov-Dec 01; 56(10):881-888. PubMed ID: 34516460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroenterologist perceptions of faecal microbiota transplantation.
    Paramsothy S; Walsh AJ; Borody T; Samuel D; van den Bogaerde J; Leong RW; Connor S; Ng W; Mitchell HM; Kaakoush NO; Kamm MA
    World J Gastroenterol; 2015 Oct; 21(38):10907-14. PubMed ID: 26478682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
    Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplantation: Information for the Pediatrician.
    Oliva-Hemker M; Kahn SA; Steinbach WJ; ;
    Pediatrics; 2023 Dec; 152(6):. PubMed ID: 37981872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation in children: current concepts.
    Gurram B; Sue PK
    Curr Opin Pediatr; 2019 Oct; 31(5):623-629. PubMed ID: 31169545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.